Pathophysiological aspects of sepsis and emergency management: A narrative review
DOI:
https://doi.org/10.33448/rsd-v12i3.40755Keywords:
Pathophysiology; Semiology; Sepsis.Abstract
Sepsis is classified as a medical emergency that describes the body's systemic immune response to a local inflammatory process, which can lead to organ dysfunction and death. Even though there is a great demand for updating medical management, the syndrome continues to be highly prevalent in Brazil and worldwide. This study is a narrative review with the purpose of discussing and describing sepsis and its pathophysiology, as well as demonstrating how this syndrome affects the personal lives of affected individuals. The following databases were used: SciElo (Scientific Electronic Library Online) and PubMed (US National Library of Medicine), with scientific data from January 10, 2023, with no language restriction and no restriction on the year of publication. Several studies show that sepsis is an alteration of the immune balance between inflammation and anti-inflammatory. Furthermore, the regulation of pro- and anti-inflammatory pathways in the face of sepsis leads to a non-local, but systemic release of cytokines, mediators and molecules related to pathogens, collaborating in the activation of coagulation and complement cascades. In short, sepsis remains a significant burden on healthcare systems around the world. However, the advances made in understanding its pathophysiology in the last 20 years surpass everything that has gone before.
References
Angus D. C., et al (2001). Epidemiologia da sepse grave nos Estados Unidos: análise da incidência, resultado e custos associados ao tratamento. Crit Care Med; 29 (7):1303-10.
Annane D. et al (2018). Glucocorticóides com ou sem Fludrocortisona no Choque Séptico. N Engl J Med; 379 (9):895-6.
Annane D., et al (2003). Epidemiologia atual do choque séptico: a Rede CUB-Réa. Am J Respiro Crit Care Med; 168 (2):165-72.
Barros, L. L.; et al. (2016). Fatores de risco associados ao agravamento de sepse em pacientes em Unidade de Terapia Intensiva. Cadernos Saúde Coletiva, 24(4).
Beal A. L. & Cerra F. B. (1994). Síndrome de falência múltipla de órgãos na década de 1990: resposta inflamatória sistêmica e disfunção orgânica. JAMA; 271 (3): 226–233.
Chousterman B. G., et al (2017). Tempestade de citocinas e patogênese da doença sepse. Semin Immunopathol. 39 :517–28.
Cohen J., et al (2004). Novo método de classificação de infecções em pacientes críticos. Crit Care Med; 32 (7):1510-26.
Elfeky S., et al (2017). As características epidemiológicas, tendências temporais, preditores de morte e disposição de alta em pacientes com diagnóstico de sepse: um estudo de coorte retrospectivo transversal. J Crit Care; 39 :48-55.
Haas S. A., et al (2016). Hiperlactatemia grave, depuração de lactato e mortalidade em pacientes críticos não selecionados. Medicina Intensiva. 42 :202–10.
Hernandez G., et al (2019). As dez armadilhas da depuração do lactato na sepse. Inten Care Med. 45 :82–5.
Hotchkiss R. S. & Karl I. E. (2003). Fisiopatologia e tratamento da sepse. N Engl J Med; 348 (2):138-50.
Jones A. E. & Puskarich M. A. (2014). Diretrizes da Surviving Sepsis Campaign 2012: atualização para médicos de emergência. Ann Emerg Med.; 63 (1):35-47.
Kluge S., et al (2018). Acidose láctica - atualização. Deutsche medizinische Wochenschrift. 143 :1082–5.
Kumar A. (2016). Viés sistemático em meta-análises de tempo para antimicrobiano em estudos de sepse. Crit Care Med. 44 :e234–5.
Liu V., et al (2014). Mortes hospitalares em pacientes com sepse de 2 coortes independentes. JAMA; 312 (1):90-2.
Martin G. S. et al. (2003). The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med;348(16):1546-54.
Martin G. S., et al (2003). A epidemiologia da sepse nos Estados Unidos de 1979 a 2000. N Engl J Med; 348 (16):1546-54.
Mayr F. B., et al (2010). Taxa de infecção e risco de disfunção aguda de órgãos como explicações para diferenças raciais na sepse grave. JAMA.; 303 (24):2495-503.
Pereira A. S. et al. (2018). Metodologia da pesquisa científica. UFSM.
Vincent J. L., et al (2009). EPIC II Group of Investigators. Estudo internacional de prevalência e desfechos de infecção em unidades de terapia intensiva. JAMA; 302 (21):2323-9.
Wacker C., et al (2013). Procalcitonina como marcador diagnóstico de sepse: revisão sistemática e metanálise. Lancet Infect Dis; 13 (5): 426–435.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Marianne Lopes Diamantino; Marcella Maciel Rios; Larissa Stefani Santos ; Karita dos Reis Lima ; Gabriel Moraes de Carvalho; Jonas Alves de Souza Neto ; Yana Martins Faria ; Anna Lídia Masson Roma ; Andreza Gonçalves Amaral; Laura Martins Cabreado
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
